Atlas Trials

Safety, Tolerability and Pharmacokinetics of NCO-48 Fumarate in Healthy Subjects

Clinical trial NCT04309526 · COMPLETED

Trial details

NCT number
NCT04309526
Sponsor
Nucorion Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatitis B
Start date
2020-03-18
Primary completion
2020-08-03
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.